Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding

NCT00293059 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

190

Enrollment

INDUSTRY

Sponsor class

Conditions

Metrorrhagia

Interventions

DRUG: Estradiol valerate/Dienogest (Natazia, Qlaira, BAY86-5027)
DRUG: Placebo

Sponsor

Bayer